AMAVITA Pantoprazol cpr 20 mg 14 pce

7680697520024 CH-69752 A02BC02 04.99.0.
AMAVITA Pantoprazol cpr 20 mg 14 pce
AMAVITA Pantoprazol cpr 20 mg 14 pce
AMAVITA Pantoprazol cpr 20 mg 14 pce
1 / 3
google

Details

Product number
6975201
CPT
-
Packaging group
14
Unit
Tablette(n)
Composition
pantoprazolum 20 mg ut pantoprazolum natricum sesquihydricum, trinatrii phosphas anhydricus, isomaltum 29.25 mg, carmellosum natricum, crospovidonum, natrii stearylis fumaras, Überzug: hypromellosum, povidonum K 25, propylenglycolum, E 171, E 172 (flavum), acidi methacrylici et ethylis acrylatis polymerisatum 1:1, triethylis citras, dimeticonum, sorbitani stearas, polysorbatum 60, silica colloidalis anhydrica, xanthani gummi, E 210 <0.65 µg, E 200, kalii hydroxidum, acidum hydrochloridum, pro compresso obducto corresp. natrium 3.58 mg.

Articles (1)

Amavita Pantoprazol 20 mg, magensaftresistente Tabletten
Magensaftresistente Tabletten
14
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
28/06/2024
Patient information leaflet
Français
28/06/2024
Patient information leaflet
Italien
28/06/2024
Professional SmPC
Allemand
28/06/2024
Professional SmPC
Français
28/06/2024
Professional SmPC
Italien
28/06/2024

Detailed composition

Substance Quantity Type Category
(N/A)
20.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
29.25 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance FNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HBESI
(N/A)
- Substance Konservierungsstoff (Conservateur)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
3.58 MG Substance HBESI

Authorization holder

Amavita Health Care AG

4704 Niederbipp

Authorization information

Swissmedic authorization number
69752
Drug name
Amavita Pantoprazol, magensaftresistente Tabletten
Galenic form
MATB
ATC Code
A02BC02
Authorization status
Z
Authorization category
Category C
Dispensation category
D
First authorization
17/05/2024
Authorization expiration date
31/12/9999
IT number
04.99.0.
Domain
Human medicine
Field of application
kurzzeitige Behandlung von Refluxsymptomen bei Erwachsenen

Packaging details

Description (FR)
AMAVITA Pantoprazol cpr 20 mg 14 pce
Description (DE)
AMAVITA Pantoprazol Tabl 20 mg 14 Stk
Market launch
17/05/2024
Narcotic (BTM)
No

Available generics

Panprax, magensaftresistente Tabletten
CHF 14.35
View
Panprax, magensaftresistente Tabletten
CHF 25.85
View
Panprax, magensaftresistente Tabletten
CHF 34.35
View
Panprax, magensaftresistente Tabletten
CHF 45.85
View
Panprax, magensaftresistente Tabletten
CHF 14.15
View
Panprax, magensaftresistente Tabletten
CHF 18.50
View
Panprax, magensaftresistente Tabletten
CHF 34.10
View
Panprax, magensaftresistente Tabletten
CHF 36.05
View
Panprax, magensaftresistente Tabletten
CHF 49.10
View
Pantoprazol axapharm, magensaftresistente Tabletten
CHF 14.10
View